|
An open-label, randomized, controlled trial to evaluate the efficacy of antihistamine premedication and infusion prolongation in prevention of hypersensitivity reaction to oxaliplatin. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
Piyada Sitthideatphaiboon |
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Amgen; AstraZeneca; MSD Oncology; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Novartis; Roche |
Research Funding - AstraZeneca; MSD Oncology; Novartis; Pfizer; Roche |
| |
|
No Relationships to Disclose |